SDY vs XBI
SPDR S&P Dividend ETF vs SPDR S&P Biotech ETF
- • SDY pays a higher dividend yield (2.35%).
Side-by-side metrics
| Metric | SDY | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.35% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $23.87B | $10.92B |
YTD return | 19.71% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.48 | 1.01 |
P/E ratio | 18.98 | — |
Last price | $163.50 | $156.41 |
Inception | — | — |
Issuer | State Street | State Street |
SDY top holdings
| ACN | Accenture PLC Class A | 4.02% |
| VZ | Verizon Communications Inc | 2.81% |
| CVX | Chevron Corp | 2.18% |
| O | Realty Income Corp | 1.91% |
| PEP | PepsiCo Inc | 1.84% |
| MDT | Medtronic PLC | 1.81% |
| TGT | Target Corp | 1.63% |
| ADP | Automatic Data Processing Inc | 1.53% |
| NKE | Nike Inc Class B | 1.52% |
| XOM | ExxonMobil Holdings Corp | 1.52% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About SDY
SDY (SPDR S&P Dividend ETF) is Highest-yielding S&P Composite 1500 dividend growers. Managed by State Street, the fund carries $23.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 2.35%. Its largest holding is Accenture PLC Class A (ACN), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 3.7%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.